#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pouchitis Juvenile psoriatic arthritis Myelodysplastic syndrome with excess blasts Growth hormone deficiency Transplant rejection Lip and/or oral cavity cancer Systemic lupus erythematosus Pyoderma gangrenosum Metastases to peritoneum Muscular dystrophy CDKL5 deficiency disorder Infertility male Dermatitis Erythema multiforme Hereditary ataxia More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy Sjogren’s syndrome – Diagnostics Chondrosarcoma – Trials in Disease Alveolar rhabdomyosarcoma – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Fragile X syndrome – Diagnostics Anaplastic thyroid cancer – Treatment Advanced systemic mastocytosis – Trials in Disease Rhabdoid tumour Gastrointestinal stromal tumour More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cft1946 Gen1055 Topotecan Hydrochloride Elvn-002-1 Ibrexafungerp Cendakimab ANGIOTENSIN II Simoctocog Alfa Fulvestrant Gelatin PARECOXIB Potato Starch Ivospemin Niflumic Acid Naltrexone Hydrochloride ZIGAKIBART Dupilumab Onfekafusp Alfa Cinnarizine Soya Oil More therapies…

    Learn about Your Condition

    Notalgia paraesthetica Autoimmune uveitis Pyoderma Pelvic venous thrombosis Cortisol abnormal Endometrial cancer stage I End stage renal disease Cleft lip and palate Malabsorption T-cell type acute leukaemia Gastrooesophageal cancer Streptococcal infection Transplantation complication H1N1 influenza Diabetic nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinički bolnički centar Zagreb (University Hospital…

Klinički bolnički centar Zagreb (University Hospital Center Zagreb)

Vinogradska Cesta 29, Zagreb, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • POLYMYXIN B SULFATE
    • Rifabutin
    • SULBACTAM SODIUM
    Croatia Greece

  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Croatia Denmark Hungary +8

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Remibrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +19

  • A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Cabozantinib
    • Belzutifan
    Austria Belgium Croatia Czechia Denmark France +6

  • Study of felzartamab compared to placebo in adults with IgA nephropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cetirizine Dihydrochloride
    • Desloratadine
    • Famotidine
    Belgium Bulgaria Croatia Czechia France Germany +5

  • Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

    Recruiting

    3 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Croatia Czechia Greece Hungary Italy Poland +1

  • Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    • Triptorelin Acetate
    • Apalutamide
    Belgium Croatia Czechia Denmark France Ireland +4

  • Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Sotagliflozin
    Belgium Bulgaria Croatia Czechia France Germany +7

  • Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Vedolizumab
    • Upadacitinib
    Austria Belgium Croatia Czechia Denmark France +12
1 2 3 … 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!